SCHEMBL30428259

SCHEMBL30428259

COc1cccc2c1nc(N)n1nc(CO)nc21

nearest known ligand 0.56

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 20/20 0.56
ADORA1 P30542 8/20 0.56
KCNH2 Q12809 7/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15845642 1.00 ADORA2A (0.56) ADORA2AADORA1KCNH2
SCHEMBL15845647 0.90 ADORA2A (0.55) ADORA2AADORA1KCNH2
SCHEMBL17897230 0.89 ADORA2A (0.60) ADORA2AADORA1KCNH2
SCHEMBL30427857 0.89 ADORA2A (0.57) ADORA2AADORA1KCNH2
SCHEMBL15845519 0.89 ADORA2A (0.57) ADORA2AADORA1KCNH2
SCHEMBL25418864 0.89 ADORA2A (0.59) ADORA2AADORA1KCNH2
SCHEMBL15845785 0.88 ADORA2A (0.53) ADORA2AADORA1KCNH2
SCHEMBL30427881 0.88 ADORA2A (0.53) ADORA2AADORA1KCNH2
SCHEMBL25212090 0.87 ADORA2A (0.55) ADORA2AADORA1KCNH2
SCHEMBL15845776 0.86 ADORA2A (0.56) ADORA2AADORA1KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4185296-A1 ADENOSINE A2A AND A2B RECEPTOR DUAL ANTAGONISTS FOR IMMUNO-ONCOLOGY Merck Sharp & Dohme LLC (US) 2023-05-31 EP disclosed
EP-4185297-A1 ADENOSINE A2A AND A2B RECEPTOR DUAL ANTAGONISTS FOR IMMUNO-ONCOLOGY Merck Sharp & Dohme LLC (US) 2023-05-31 EP disclosed